Fox Run Management’s Immunovant IMVT Stock Holding History

Fox Run Management’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$229K	Buy
2024 Q1	–	Sell
2023 Q4	$612K	Buy
2023 Q2	–	Sell
2023 Q1	$200K	Buy
2022 Q4	$227K	Buy
2022 Q1	–	Sell
2021 Q4	$92K	Sell
2021 Q3	$121K	Buy